TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Companion Diagnostics (CDx) Development Services Market Research Report 2022

Global Companion Diagnostics (CDx) Development Services Market Research Report 2022

  • Category:Life Sciences
  • Published on : 07 October 2022
  • Pages :103
  • Formats:
  • Report Code:SMR-7420645
OfferClick for best price

Best Price: $2320

Companion Diagnostics CDx Development Services Market Size, Share 2022


Market Analysis and Insights: Global Companion Diagnostics CDx Development Services Market

The global Companion Diagnostics CDx Development Services market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Companion Diagnostics CDx Development Services market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Companion Diagnostics CDx Development Services market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Companion Diagnostics CDx Development Services market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Companion Diagnostics CDx Development Services market.

Global Companion Diagnostics CDx Development Services Scope and Market Size

Companion Diagnostics (CDx) Development Services market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Companion Diagnostics (CDx) Development Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Feasibility Studies

Assay Development

Analytical Validation

Clinical Validation

Others

Segment by Application

Infectious Diseases

Neurological Disorders

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Geneuity-Clinical Research Services

Interpace Biosciences

Labcorp

Quest Diagnostics

Q? Solutions

ResearchDx

Almac Diagnostic Services

Biocartis

Cerba Research

Eurofins Scientific

MLM Medical Labs

Qiagen

BGI Genomics

MEDx Translational Medicine

Medical Biological Laboratories (MBL)

Novogene

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Companion Diagnostics CDx Development Services product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Companion Diagnostics CDx Development Services, with price, sales, revenue, and global market share of Companion Diagnostics CDx Development Services from 2019 to 2022.

Chapter 3, the Companion Diagnostics CDx Development Services competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Companion Diagnostics CDx Development Services breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Companion Diagnostics CDx Development Services market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Companion Diagnostics CDx Development Services.

Chapter 13, 14, and 15, to describe Companion Diagnostics CDx Development Services sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Companion Diagnostics CDx Development Services Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Companion Diagnostics (CDx) Development Services Market Research Report 2022
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 103 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Feasibility Studies
1.2.3 Assay Development
1.2.4 Analytical Validation
1.2.5 Clinical Validation
1.2.6 Others
1.3 Market by Application
1.3.1 Global Companion Diagnostics (CDx) Development Services Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Infectious Diseases
1.3.3 Neurological Disorders
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Companion Diagnostics (CDx) Development Services Market Perspective (2017-2028)
2.2 Companion Diagnostics (CDx) Development Services Growth Trends by Region
2.2.1 Companion Diagnostics (CDx) Development Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Companion Diagnostics (CDx) Development Services Historic Market Size by Region (2017-2022)
2.2.3 Companion Diagnostics (CDx) Development Services Forecasted Market Size by Region (2023-2028)
2.3 Companion Diagnostics (CDx) Development Services Market Dynamics
2.3.1 Companion Diagnostics (CDx) Development Services Industry Trends
2.3.2 Companion Diagnostics (CDx) Development Services Market Drivers
2.3.3 Companion Diagnostics (CDx) Development Services Market Challenges
2.3.4 Companion Diagnostics (CDx) Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostics (CDx) Development Services Players by Revenue
3.1.1 Global Top Companion Diagnostics (CDx) Development Services Players by Revenue (2017-2022)
3.1.2 Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Players (2017-2022)
3.2 Global Companion Diagnostics (CDx) Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostics (CDx) Development Services Revenue
3.4 Global Companion Diagnostics (CDx) Development Services Market Concentration Ratio
3.4.1 Global Companion Diagnostics (CDx) Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostics (CDx) Development Services Revenue in 2021
3.5 Companion Diagnostics (CDx) Development Services Key Players Head office and Area Served
3.6 Key Players Companion Diagnostics (CDx) Development Services Product Solution and Service
3.7 Date of Enter into Companion Diagnostics (CDx) Development Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostics (CDx) Development Services Breakdown Data by Type
4.1 Global Companion Diagnostics (CDx) Development Services Historic Market Size by Type (2017-2022)
4.2 Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Type (2023-2028)
5 Companion Diagnostics (CDx) Development Services Breakdown Data by Application
5.1 Global Companion Diagnostics (CDx) Development Services Historic Market Size by Application (2017-2022)
5.2 Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Companion Diagnostics (CDx) Development Services Market Size (2017-2028)
6.2 North America Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022)
6.3 North America Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Companion Diagnostics (CDx) Development Services Market Size (2017-2028)
7.2 Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022)
7.3 Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size (2017-2028)
8.2 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022)
8.3 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Companion Diagnostics (CDx) Development Services Market Size (2017-2028)
9.2 Latin America Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022)
9.3 Latin America Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size (2017-2028)
10.2 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022)
10.3 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Geneuity-Clinical Research Services
11.1.1 Geneuity-Clinical Research Services Company Detail
11.1.2 Geneuity-Clinical Research Services Business Overview
11.1.3 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Introduction
11.1.4 Geneuity-Clinical Research Services Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.1.5 Geneuity-Clinical Research Services Recent Development
11.2 Interpace Biosciences
11.2.1 Interpace Biosciences Company Detail
11.2.2 Interpace Biosciences Business Overview
11.2.3 Interpace Biosciences Companion Diagnostics (CDx) Development Services Introduction
11.2.4 Interpace Biosciences Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.2.5 Interpace Biosciences Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Detail
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Companion Diagnostics (CDx) Development Services Introduction
11.3.4 Labcorp Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.3.5 Labcorp Recent Development
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Detail
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Companion Diagnostics (CDx) Development Services Introduction
11.4.4 Quest Diagnostics Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.4.5 Quest Diagnostics Recent Development
11.5 Q? Solutions
11.5.1 Q? Solutions Company Detail
11.5.2 Q? Solutions Business Overview
11.5.3 Q? Solutions Companion Diagnostics (CDx) Development Services Introduction
11.5.4 Q? Solutions Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.5.5 Q? Solutions Recent Development
11.6 ResearchDx
11.6.1 ResearchDx Company Detail
11.6.2 ResearchDx Business Overview
11.6.3 ResearchDx Companion Diagnostics (CDx) Development Services Introduction
11.6.4 ResearchDx Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.6.5 ResearchDx Recent Development
11.7 Almac Diagnostic Services
11.7.1 Almac Diagnostic Services Company Detail
11.7.2 Almac Diagnostic Services Business Overview
11.7.3 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Introduction
11.7.4 Almac Diagnostic Services Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.7.5 Almac Diagnostic Services Recent Development
11.8 Biocartis
11.8.1 Biocartis Company Detail
11.8.2 Biocartis Business Overview
11.8.3 Biocartis Companion Diagnostics (CDx) Development Services Introduction
11.8.4 Biocartis Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.8.5 Biocartis Recent Development
11.9 Cerba Research
11.9.1 Cerba Research Company Detail
11.9.2 Cerba Research Business Overview
11.9.3 Cerba Research Companion Diagnostics (CDx) Development Services Introduction
11.9.4 Cerba Research Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.9.5 Cerba Research Recent Development
11.10 Eurofins Scientific
11.10.1 Eurofins Scientific Company Detail
11.10.2 Eurofins Scientific Business Overview
11.10.3 Eurofins Scientific Companion Diagnostics (CDx) Development Services Introduction
11.10.4 Eurofins Scientific Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.10.5 Eurofins Scientific Recent Development
11.11 MLM Medical Labs
11.11.1 MLM Medical Labs Company Detail
11.11.2 MLM Medical Labs Business Overview
11.11.3 MLM Medical Labs Companion Diagnostics (CDx) Development Services Introduction
11.11.4 MLM Medical Labs Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.11.5 MLM Medical Labs Recent Development
11.12 Qiagen
11.12.1 Qiagen Company Detail
11.12.2 Qiagen Business Overview
11.12.3 Qiagen Companion Diagnostics (CDx) Development Services Introduction
11.12.4 Qiagen Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.12.5 Qiagen Recent Development
11.13 BGI Genomics
11.13.1 BGI Genomics Company Detail
11.13.2 BGI Genomics Business Overview
11.13.3 BGI Genomics Companion Diagnostics (CDx) Development Services Introduction
11.13.4 BGI Genomics Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.13.5 BGI Genomics Recent Development
11.14 MEDx Translational Medicine
11.14.1 MEDx Translational Medicine Company Detail
11.14.2 MEDx Translational Medicine Business Overview
11.14.3 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Introduction
11.14.4 MEDx Translational Medicine Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.14.5 MEDx Translational Medicine Recent Development
11.15 Medical Biological Laboratories (MBL)
11.15.1 Medical Biological Laboratories (MBL) Company Detail
11.15.2 Medical Biological Laboratories (MBL) Business Overview
11.15.3 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Introduction
11.15.4 Medical Biological Laboratories (MBL) Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.15.5 Medical Biological Laboratories (MBL) Recent Development
11.16 Novogene
11.16.1 Novogene Company Detail
11.16.2 Novogene Business Overview
11.16.3 Novogene Companion Diagnostics (CDx) Development Services Introduction
11.16.4 Novogene Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.16.5 Novogene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Feasibility Studies
Table 3. Key Players of Assay Development
Table 4. Key Players of Analytical Validation
Table 5. Key Players of Clinical Validation
Table 6. Key Players of Others
Table 7. Global Companion Diagnostics (CDx) Development Services Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Companion Diagnostics (CDx) Development Services Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Companion Diagnostics (CDx) Development Services Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Companion Diagnostics (CDx) Development Services Market Share by Region (2017-2022)
Table 11. Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Companion Diagnostics (CDx) Development Services Market Share by Region (2023-2028)
Table 13. Companion Diagnostics (CDx) Development Services Market Trends
Table 14. Companion Diagnostics (CDx) Development Services Market Drivers
Table 15. Companion Diagnostics (CDx) Development Services Market Challenges
Table 16. Companion Diagnostics (CDx) Development Services Market Restraints
Table 17. Global Companion Diagnostics (CDx) Development Services Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Companion Diagnostics (CDx) Development Services Market Share by Players (2017-2022)
Table 19. Global Top Companion Diagnostics (CDx) Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics (CDx) Development Services as of 2021)
Table 20. Ranking of Global Top Companion Diagnostics (CDx) Development Services Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Companion Diagnostics (CDx) Development Services Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Companion Diagnostics (CDx) Development Services Product Solution and Service
Table 24. Date of Enter into Companion Diagnostics (CDx) Development Services Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Companion Diagnostics (CDx) Development Services Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Type (2017-2022)
Table 28. Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Type (2023-2028)
Table 30. Global Companion Diagnostics (CDx) Development Services Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Application (2017-2022)
Table 32. Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Application (2023-2028)
Table 34. North America Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028) & (US$ Million)
Table 44. Geneuity-Clinical Research Services Company Detail
Table 45. Geneuity-Clinical Research Services Business Overview
Table 46. Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Product
Table 47. Geneuity-Clinical Research Services Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
Table 48. Geneuity-Clinical Research Services Recent Development
Table 49. Interpace Biosciences Company Detail
Table 50. Interpace Biosciences Business Overview
Table 51. Interpace Biosciences Companion Diagnostics (CDx) Development Services Product
Table 52. Interpace Biosciences Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
Table 53. Interpace Biosciences Recent Development
Table 54. Labcorp Company Detail
Table 55. Labcorp Business Overview
Table 56. Labcorp Companion Diagnostics (CDx) Development Services Product
Table 57. Labcorp Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
Table 58. Labcorp Recent Development
Table 59. Quest Diagnostics Company Detail
Table 60. Quest Diagnostics Business Overview
Table 61. Quest Diagnostics Companion Diagnostics (CDx) Development Services Product
Table 62. Quest Diagnostics Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
Table 63. Quest Diagnostics Recent Development
Table 64. Q? Solutions Company Detail
Table 65. Q? Solutions Business Overview
Table 66. Q? Solutions Companion Diagnostics (CDx) Development Services Product
Table 67. Q? Solutions Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
Table 68. Q? Solutions Recent Development
Table 69. ResearchDx Company Detail
Table 70. ResearchDx Business Overview
Table 71. ResearchDx Companion Diagnostics (CDx) Development Services Product
Table 72. ResearchDx Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
Table 73. ResearchDx Recent Development
Table 74. Almac Diagnostic Services Company Detail
Table 75. Almac Diagnostic Services Business Overview
Table 76. Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Product
Table 77. Almac Diagnostic Services Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
Table 78. Almac Diagnostic Services Recent Development
Table 79. Biocartis Company Detail
Table 80. Biocartis Business Overview
Table 81. Biocartis Companion Diagnostics (CDx) Development Services Product
Table 82. Biocartis Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
Table 83. Biocartis Recent Development
Table 84. Cerba Research Company Detail
Table 85. Cerba Research Business Overview
Table 86. Cerba Research Companion Diagnostics (CDx) Development Services Product
Table 87. Cerba Research Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
Table 88. Cerba Research Recent Development
Table 89. Eurofins Scientific Company Detail
Table 90. Eurofins Scientific Business Overview
Table 91. Eurofins Scientific Companion Diagnostics (CDx) Development Services Product
Table 92. Eurofins Scientific Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
Table 93. Eurofins Scientific Recent Development
Table 94. MLM Medical Labs Company Detail
Table 95. MLM Medical Labs Business Overview
Table 96. MLM Medical Labs Companion Diagnostics (CDx) Development ServicesProduct
Table 97. MLM Medical Labs Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
Table 98. MLM Medical Labs Recent Development
Table 99. Qiagen Company Detail
Table 100. Qiagen Business Overview
Table 101. Qiagen Companion Diagnostics (CDx) Development ServicesProduct
Table 102. Qiagen Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
Table 103. Qiagen Recent Development
Table 104. BGI Genomics Company Detail
Table 105. BGI Genomics Business Overview
Table 106. BGI Genomics Companion Diagnostics (CDx) Development ServicesProduct
Table 107. BGI Genomics Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
Table 108. BGI Genomics Recent Development
Table 109. MEDx Translational Medicine Company Detail
Table 110. MEDx Translational Medicine Business Overview
Table 111. MEDx Translational Medicine Companion Diagnostics (CDx) Development ServicesProduct
Table 112. MEDx Translational Medicine Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
Table 113. MEDx Translational Medicine Recent Development
Table 114. Medical Biological Laboratories (MBL) Company Detail
Table 115. Medical Biological Laboratories (MBL) Business Overview
Table 116. Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development ServicesProduct
Table 117. Medical Biological Laboratories (MBL) Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
Table 118. Medical Biological Laboratories (MBL) Recent Development
Table 119. Novogene Company Detail
Table 120. Novogene Business Overview
Table 121. Novogene Companion Diagnostics (CDx) Development ServicesProduct
Table 122. Novogene Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022) & (US$ Million)
Table 123. Novogene Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Diagnostics (CDx) Development Services Market Share by Type: 2021 VS 2028
Figure 2. Feasibility Studies Features
Figure 3. Assay Development Features
Figure 4. Analytical Validation Features
Figure 5. Clinical Validation Features
Figure 6. Others Features
Figure 7. Global Companion Diagnostics (CDx) Development Services Market Share by Application in 2021 & 2028
Figure 8. Infectious Diseases Case Studies
Figure 9. Neurological Disorders Case Studies
Figure 10. Companion Diagnostics (CDx) Development Services Report Years Considered
Figure 11. Global Companion Diagnostics (CDx) Development Services Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Companion Diagnostics (CDx) Development Services Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Companion Diagnostics (CDx) Development Services Market Share by Region: 2021 VS 2028
Figure 14. Global Companion Diagnostics (CDx) Development Services Market Share by Players in 2021
Figure 15. Global Top Companion Diagnostics (CDx) Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics (CDx) Development Services as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Companion Diagnostics (CDx) Development Services Revenue in 2021
Figure 17. North America Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Companion Diagnostics (CDx) Development Services Market Share by Country (2017-2028)
Figure 19. United States Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Companion Diagnostics (CDx) Development Services Market Share by Country (2017-2028)
Figure 23. Germany Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Share by Region (2017-2028)
Figure 31. China Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Companion Diagnostics (CDx) Development Services Market Share by Country (2017-2028)
Figure 39. Mexico Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Share by Country (2017-2028)
Figure 43. Turkey Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Geneuity-Clinical Research Services Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
Figure 46. Interpace Biosciences Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
Figure 47. Labcorp Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
Figure 48. Quest Diagnostics Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
Figure 49. Q? Solutions Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
Figure 50. ResearchDx Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
Figure 51. Almac Diagnostic Services Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
Figure 52. Biocartis Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
Figure 53. Cerba Research Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
Figure 54. Eurofins Scientific Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
Figure 55. MLM Medical Labs Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
Figure 56. Qiagen Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
Figure 57. BGI Genomics Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
Figure 58. MEDx Translational Medicine Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
Figure 59. Medical Biological Laboratories (MBL) Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
Figure 60. Novogene Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount